JXN Stock Analysis: Jackson Financial | NYSE
Insurance - Life | NYSE, USA | Market Cap: 8.763m USD | 12M Return: 37.5% | US46817M1071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 81.1M
EPS Trend: 63.4%
Qual. Beats: 0
Rev. Trend: 82.2%
Qual. Beats: -1
Warnings
Tailwinds
Seasonality 4.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Jackson Financial Inc. (NYSE: JXN) is a Lansing, Michigan-based provider of retirement income, savings, and life insurance products, primarily serving U.S. retail investors. The company operates through three segments: Retail Annuities (variable, fixed index, fixed, payout, and registered index-linked annuities), Institutional Products (guaranteed investment contracts, funding agreements, FHLB-backed agreements, and medium-term funding agreement-backed notes), and Closed Life and Annuity Blocks (life insurance and legacy annuity policies). It also offers investment management services and distributes through independent broker-dealers, wirehouses, banks, RIAs, third-party platforms, and insurance agents.
The company was incorporated in 2006 and spun off from Prudential Financial, completing its IPO in September 2021. Within the life insurance and annuities industry, Jackson is among the larger U.S. annuity writers, with fixed index and registered index-linked annuities representing a meaningful share of recent industry growth as investors seek principal-protected retirement income options.
- Long-term Treasury yields expand annuity spread margins
- Equity market volatility raises variable annuity hedging costs
- Share buyback program accelerates capital return to shareholders
| Net Income: 103.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.04 > 1.0 |
| NWC/Revenue: -124.4% < 20% (prev 941.2%; Δ -1.07k% < -1%) |
| CFO/TA 0.02 > 3% & CFO 5.88b > Net Income 103.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (70.3m) vs 12m ago -2.29% < -2% |
| Gross Margin: 83.06% > 18% (prev 25.15%; Δ 57.91% > 0.5%) |
| Asset Turnover: 1.83% > 50% (prev 1.60%; Δ 0.24% > 0%) |
| Interest Coverage Ratio: -0.21 > 6 (EBIT TTM -21.0m / Interest Expense TTM 102.0m) |
| A: -0.02 (Total Current Assets 5.99b - Total Current Liabilities 14.1b) / Total Assets 367b |
| B: 0.02 (Retained Earnings 7.55b / Total Assets 367b) |
| C: -0.00 (EBIT TTM -21.0m / Avg Total Assets 355b) |
| D: 0.03 (Book Value of Equity 9.96b / Total Liabilities 357b) |
| Altman-Z'' = -0.05 = B |
| DSRI: 0.77 (Receivables 19.2b/21.1b, Revenue 6.51b/5.49b) |
| GMI: 0.30 (GM 25.15% / 83.06%) |
| AQI: 1.23 (AQ_t 0.98 / AQ_t-1 0.80) |
| SGI: 1.19 (Revenue 6.51b / 5.49b) |
| TATA: -0.02 (NI 103.0m - CFO 5.88b) / TA 367b) |
| Beneish M = -3.58 (Cap -4..+1) = AAA |
As of September 21, 2026, the stock is trading at USD 132.67 with a total of 3,380,956 shares traded. Over the past week, the price has changed by -3.32%, over one month by -0.98%, over three months by +25.02% and over the past year by +37.51%.
Current recommended Stop Loss: 126.60 (which is 4.6% or 1.4 ATR below the current price).
Jackson Financial has received a consensus analysts rating of 2.80. Therefore, it is recommended to hold JXN.
- StrongBuy: 0
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 146 | 10% |
P/E Trailing = 142.1758
P/S = 1.338
P/B = 0.9848
Revenue TTM = 6.51b USD
EBIT TTM = -21.0m USD
EBITDA TTM = -21.0m USD
Long Term Debt = 4.59b USD (from longTermDebt, last quarter)
Short Term Debt = 649.0m USD (from shortTermDebt, last quarter)
Debt = 5.24b USD (corrected: LT Debt 4.59b + ST Debt 649.0m)
Net Debt = -53.0b USD (calculated: Debt 5.24b - CCE 58.2b)
Enterprise Value = 8.76b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = -0.21 (Ebit TTM -21.0m / Interest Expense TTM 102.0m)
EV/FCF = 1.49x (Enterprise Value 8.76b / FCF TTM 5.88b)
FCF Yield = 67.16% (FCF TTM 5.88b / Enterprise Value 8.76b)
FCF Margin = 90.36% (FCF TTM 5.88b / Revenue TTM 6.51b)
Net Margin = 1.58% (Net Income TTM 103.0m / Revenue TTM 6.51b)
Gross Margin = 83.06% ((Revenue TTM 6.51b - Cost of Revenue TTM 1.10b) / Revenue TTM)
Gross Margin QoQ = -43.45% (prev 22.09%)
Tobins Q-Ratio = 0.02 (Enterprise Value 8.76b / Total Assets 367b)
Interest Expense / Debt = 1.95% (Interest Expense 102.0m / Debt 5.24b)
Taxrate = 0.75% (5.00m / 665.0m)
NOPAT = -20.8m (EBIT -21.0m * (1 - 0.75%)) [loss with tax shield]
Current Ratio = 0.42 (Total Current Assets 5.99b / Total Current Liabilities 14.1b)
Debt / Equity = 0.53 (Debt 5.24b / totalStockholderEquity, last quarter 9.96b)
Debt / EBITDA = 2.52k (out of range, set to none) (Net Debt -53.0b / EBITDA -21.0m)
Debt / FCF = -9.00 (Net Debt -53.0b / FCF TTM 5.88b)
Total Stockholder Equity = 9.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.03% (Net Income 103.0m / Total Assets 367b)
RoE = 1.04% (Net Income TTM 103.0m / Total Stockholder Equity 9.91b)
RoCE = -0.14% (EBIT -21.0m / Capital Employed (Equity 9.91b + L.T.Debt 4.59b))
RoIC = -0.01% (negative operating profit) (NOPAT -20.8m / Invested Capital 353b)
WACC = 7.15% (E(8.76b)/V(14.0b) * Re(10.28%) + D(5.24b)/V(14.0b) * Rd(1.95%) * (1-Tc(0.01)))
Discount Rate = 10.28% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.14 | Cagr: -4.99%
[DCF] Terminal Value 75.96% ; FCFF base≈5.79b ; Y1≈6.01b ; Y5≈6.81b
[DCF] Fair Price = 2.33k (EV 105b - Net Debt -53.0b = Equity 158b / Shares 67.7m; r=8.35% [WACC [floored]]; 5y FCF grow 4.05% → 2.50% )
EPS Correlation: 63.40 | EPS CAGR: 15.77% | SUE: 0.83 | # QB: 0
Revenue Correlation: 82.16 | Revenue CAGR: 45.52% | SUE: -0.96 | # QB: -1
EPS current Quarter (2026-09-30): EPS=6.99 | Chg30d=+16.21% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=26.87 | Chg30d=+16.05% | Revisions=+25% | GrowthEPS=+18.5% | GrowthRev=+20.1%
EPS next Year (2027-12-31): EPS=30.81 | Chg30d=+13.54% | Revisions=+57% | GrowthEPS=+14.6% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: +67% (up=6, down=0)